ArticleExploration of targeted anti-tumor therapy2025
Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors.
Yana K Mangasarova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.